International Journal of Innovative Pharmaceutical Sciences and Research

Similar documents
Diagnosis and Management of Asthma in Children based on the British Thoracic Society and Scottish Intercollegiate Guidelines Network September 2016

On completion of this chapter you should be able to: discuss the stepwise approach to the pharmacological management of asthma in children

Diagnosis, Treatment and Management of Asthma

RESPIRATORY CARE IN GENERAL PRACTICE

Diagnosis, Assessment, Monitoring and Pharmacological Treatment of Asthma

ASTHMA What Keeps the Wheeze Away. Dr. Janice Bacon MPHCA Annual Conference June 2016

ASTHMA CARE FOR CHILDREN BASKET OF CARE SUBCOMMITTEE Report to: Minnesota Department of Health. June 22, 2009

Asthma Management for the Athlete

(Asthma) Diagnosis, monitoring and chronic asthma management

HealthPartners Care Coordination Clinical Care Planning and Resource Guide ASTHMA

A preliminary assessment of nurses asthma education needs and the effect of a training. programme in an urban tertiary healthcare facility.

In 2002, it was reported that 72 of 1000

THE NHLBI GUIDELINES: WHERE DO WE STAND AND WHAT IS THE NEW DIRECTION FROM THE NAEPP?

ADULT ASTHMA GUIDE SUMMARY. This summary provides busy health professionals with key guidance for assessing and treating adult asthma.

Outpatient Guideline for the Diagnosis and Management of Asthma

Asthma Description. Asthma is a disease that affects the lungs defined as a chronic inflammatory disorder of the airways.

SCREENING AND PREVENTION

GINA. At-A-Glance Asthma Management Reference. for adults, adolescents and children 6 11 years. Updated 2017

Management of wheeze in pre-school children. Prof Colin Robertson, Respiratory Medicine, Royal Children s Hospital, Melbourne

Chitra C. Nair et al. Int. Res. J. Pharm. 2014, 5 (5) INTERNATIONAL RESEARCH JOURNAL OF PHARMACY

Asthma: Chronic Management. Yung-Yang Liu, MD Attending physician, Chest Department Taipei Veterans General Hospital April 26, 2015

ROLE OF CLINICAL PHARMACIST IN IMPACT OF PATIENT COUNSELLING IN ASTHMATIC PATIENTS

Pathology of Asthma Epidemiology

Asthma Medications: Information for Children and Families. What You Need to Know about Medicines for Asthma

Some Facts About Asthma

Asthma Update A/Prof. John Abisheganaden. Senior Consultant, Dept Of Respiratory & Crit Care Medicine Tan Tock Seng Hospital

Omalizumab (Xolair ) ( Genentech, Inc., Novartis Pharmaceuticals Corp.) September Indication

Evaluation of Student Pharmacist and Pharmacist Impact on Disease State Management and Patient Satisfaction in Adult Patients with Asthma

Presented by the California Academy of Family Physicians 2013/California Academy of Family Physicians

Bronchial asthma. E. Cserháti 1 st Department of Paediatrics. Lecture for english speaking students 5 February 2013

Viral-Induced Asthma:

Allwin Mercer Dr Andrew Zurek

Clinical Practice Guideline: Asthma

Asthma in the Athlete

Asthma. chapter 7. Overview

Interventions to improve adherence to inhaled steroids for asthma. Respiratory department

Alberta Childhood Asthma Pathway for Primary Care

The Asthma Guidelines: Diagnosis and Assessment of Asthma

Pathway diagrams Annex F

Australian Asthma Handbook. Key table and figures Version 1.2

CME/CE POSTTEST CME/CE QUESTIONS

Asthma in Pediatric Patients. DanThuy Dao, D.O., FAAP. Disclosures. None

ASTHMA. Epidemiology. Pathophysiology. Diagnosis. IAP UG Teaching slides

Study of dynamic lung parameters in bronchial Asthma

How far are we from adhering to national asthma guidelines: The awareness factor

ASTHMA IN THE PEDIATRIC POPULATION

Biologic Agents in the treatment of Severe Asthma

Improving the Management of Asthma to Improve Patient Adherence and Outcomes

New data from the Centers for Disease

Copyright, ICKE, Inc. All rights reserved. The Knowledge, Attitude, and Self-Efficacy. Asthma Questionnaire

The burden of asthma on the US Healthcare system and for the State of Texas is enormous. The causes of asthma are multifactorial and well known.

Outcome, classification and management of wheezing in preschool children Paul L.P. Brand

TREAMENT OF RECURRENT VIRUS-INDUCED WHEEZING IN YOUNG CHILDREN. Dr Lại Lê Hưng Respiratory Department

Asthma Basic Facts. Staying safe and well with asthma. For people with asthma and their carers.

Leeds West CCG Paediatric asthma project. January 2015-January 2017

+ Asthma and Athletics

Asthma. Jill Waldron Respiratory Specialist Nurse

Ivax Pharmaceuticals UK Sponsor Submission to the National Institute for Health and Clinical Excellence

Clinical Implications of Asthma Phenotypes. Michael Schatz, MD, MS Department of Allergy

Because the more you know, the better you ll feel.

Glen Ellyn Pharmacy Complementary Asthma Management Program Initial Visit

Improving Outcomes in the Management & Treatment of Asthma. April 21, Spring Managed Care Forum

Asthma By Mayo Clinic staff

Respiratory Health. Asthma and COPD

The Burden of Asthma in Mississippi:

Long-Term Management of Bronchial Asthma and Wheezy Chest in Children

National Asthma Educator Certification Board Detailed Content Outline

2014 Physician Quality Reporting System Data Collection Form: Asthma (for patients aged 5-64)

Roflumilast (Daxas) for chronic obstructive pulmonary disease

Because the more you know, the better you ll feel.

Tips on managing asthma in children

Asthma - Chronic. Presentations of asthma Cough Wheeze Breathlessness Chest tightness

CMS Asthma Education Program

Pharmacoeconomic Analysis of Asthma in Pediatric Patients in Tertiary Care Hospital in Kerala

ASTHMA-COPD OVERLAP SYNDROME 2018: What s All the Fuss?

Significance. Asthma Definition. Focus on Asthma

Prospective study to assess knowledge regarding wheezing disorders among mothers of children aged between 6 months to 10 years: hospital based study

Connecting Health & Housing: Asthma and the Home. Presented by: The California-Nevada Public Health Training Center

NICE guideline Published: 29 November 2017 nice.org.uk/guidance/ng80

LivingWith Asthma. A Guide to Understanding Asthma...

James P. Kemp, MD; Margaret C. Minkwitz, PhD; Catherine M. Bonuccelli, MD; and Marshelle S. Warren, MD

Chronic Obstructive Pulmonary Disease

Assessment of the Health Related Effects of Compliance Optimization in Asthma through use of SMS

ASTHMA PROTOCOL CELLO

Medicine Dr. Kawa Lecture 4 - Treatment of asthma :

Basic mechanisms disturbing lung function and gas exchange

Nancy Davis, RRT, AE-C

Q. What is a Peak-Flow Meter? A. It is an instrument that measures Peak Expiratory Flow Rate (PEFR). PEFR is the amount of air a person can blow out

Chronic persistent asthma presenting to an accident and emergency department compliance with B.T.S. guidelines

Asthma. Guide to Good Health. Healthy Living Guide

Asthma: diagnosis and monitoring

Asthma in Pregnancy. Asthma. Chronic Airway Inflammation. Objective Measures of Airflow. Peak exp. flow rate (PEFR)

Asthma training. Mike Levin Division of Asthma and Allergy Red Cross Hospital

MANAGING ASTHMA. Nancy Davis, RRT, AE-C

Prevalence of Asthma among University Students and Workers in Khartoum State, Sudan

Asthma and IAQ. Lani Wheeler, MD, Medical Officer Sarah Merkle, MPH, Program Analyst

Asthma 2015: Establishing and Maintaining Control

PATHOLOGY & PATHOPHYSIOLOGY

Known Allergies: Shellfish. Symptoms: abdominal pain, nausea, diarrhea, or vomiting. congestion, trouble breathing, or wheezing.

Asthma Assessment & Review

Transcription:

International Journal of Innovative Pharmaceutical Sciences and Research www.ijipsr.com MANAGEMENT OF BRONCHIAL ASTHMA IN KHARTOUM STATE HOSPITALS 1 Dr. Yagin Ibrahim Sid Ahmed Ali*, 2 Dr. Eltayeb Mohammed Eltayeb Gamereldeen 1 Sudan- Khartoum, Omdurman, Elwaha, Elwadi Street, Sq. 1, Home NO.239, SUDAN 2 Omdurman Islamic University, College of Postgraduates Studies, Faculty of Pharmacy, SUDAN Abstract Bronchial asthma is considered as a major public health problem in many countries. (WHO, 2014) Asthma defined as a chronic inflammatory disorder of the airways causes recurrent episodes of wheezing, breathlessness, chest tightness, and coughing, particularly at night or in the early morning. Objectives of the research, to find out prevalence and control of asthma among different age and gender groups of Sudanese asthmatic patients, to check if standard treatment guidelines exist at Alnaw Teaching Hospital and adhered, to assess the effectiveness of drugs used through follow up of patients over a specified period of time, to determine the important role of clinical pharmacist, if any, in treatment of asthma and monitoring of asthmatic patients and to educate the patient about the disease and medications in order to improve the health status and quality of life with help of questionnaire with patient counseling. Prospective hospital based survey to be conducted on 122 asthmatic patients selected randomly in both genders and adults who visit the respiratory departments in Alnaw Teaching Hospital, during study period, October 2013-December 2014. Data will be analyzed by SPSS soft ware version 17, with confidence interval 95%; (CP 0.05) using appropriate tests. Keywords: Bronchial Asthma, Management, Diagnosis, severity, drugs, control, prevention, plan, education, occupation, missed days, ER visits, hospital admissions, aggravating factors, symptoms, exercise, activities limitation, seasonal relations. Corresponding Author Dr. Yagin Ibrahim Sid Ahmed Ali Department of Clinical Pharmacy, Sudan- Khartoum, Omdurman, Elwaha, Elwadi Street, Sq. 1, Home NO.239, SUDAN Email: yagin777@gmail.com Mobile: 00249912148854 Available online: www.ijipsr.com November Issue 2647

INTRODUCTION Asthma is a chronic disease characterized by recurrent attacks of breathlessness and wheezing, which vary in severity and frequency from person to person. (WHO, 2014). Symptoms may occur several times in a day or week in affected individuals, and for some people become worse during physical activity or at night. Recurrent asthma symptoms frequently cause sleeplessness, daytime fatigue, reduced activity levels and school and work absenteeism. (WHO, 2014). According to WHO estimates, 235 million people suffer from asthma. Asthma is the most common chronic disease among children. Asthma is not just a public health problem for high income countries: it occurs in all countries regardless of level of development. Over 80% of asthma deaths occurs in low and lower-middle income countries. (WHO, 2014). An estimated 14 to 15 million persons in the United States have asthma (about 5% of the population). Asthma is the most common chronic disease among children in the United States, with approximately 5 million children affected. Over the past two decades in the United States, the prevalence of asthma has increased by 75%, whereas the rate in children younger than age 5 has increased 160%.(Kelly, H.W. and Sorkness C. A., 2005). Asthma represents a complex genetic disorder in that the asthma phenotype is likely a result of polygenic inheritance or different combinations of genes. Initial searches were focused on establishing links between atopy (genetically determined state of hypersensitivity to environmental allergens) Thus, although genetic predisposition to atopy is a significant risk factor for developing asthma, not all atopic individuals develop asthma, nor do all asthmatics exhibit atopy. (Kelly, H.W. and Sorkness C. A., 2005). Occupational asthma in previously healthy individuals emphasizes the effect of environment on the development of asthma. (Kelly, H.W. and Sorkness C. A., 2005). Viral respiratory tract infections remain the single most significant precipitant of severe asthma in children and are an important trigger in adults as well. Other possible factors include air pollution, sinusitis, food preservatives, and drugs. (Kelly, H.W. and Sorkness C. A., 2005). High proportions of children are reported to have asthma symptoms in Sudan, including 12% of children in Khartoum. (El Sony, A. I., et al. 2013). Asthma has never been a public health priority in Sudan. Lack of peak flow meters for diagnosis, numerous stock outs and inconsistent distribution of essential asthma drugs are frequent; also, the workforce is unprepared to tackle chronic asthma and the long term management of asthma patients. (El Sony, A. I., et al. 2013). A survey conducted in 2003 revealed that 95% of patients paid the full cost for Available online: www.ijipsr.com November Issue 2648

expensive drugs, <2% of them received regular treatment from a single facility and there was no asthma management plan. (El Sony, A. I., et al. 2013) Classification of asthma severity in adults: 1. Intermittent asthma 2. Mild persistent asthma 3. Moderate persistent asthma Severe persistent asthma (Harman, J. and Markham, S., 2006) Drugs used in the management of asthma include beta agonists, antimuscarinic bronchodilators, theophylline, corticosteroids, cromoglicate and nedocromil, and leukotriene receptor antagonists. (Clausen and Bosse, 2009) These drugs to management of chronic asthma and acute severe asthma. (Clausen and Bosse, 2009) RESEARCH METHODOLOGY Prospective hospital based survey to be conducted on 122 asthmatic patients selected randomly in both genders and adults who visit the respiratory departments in Alnaw Teaching Hospital, during study period, October 2013_ December 2014. Data will be analyzed by SPSS soft ware version 17, with confidence interval 95%; (CP 0.05) using appropriate tests. Data will be gathered from patients' medical records, physicians, clinical pharmacists who care for these patients, sisters, missing information will be collected from patients themselves by using questionnaire to fill all the predetermined study variables which include: patients demographics, causes of asthma, reason for visiting the hospital, control of the disease, severity of the disease, prescribed medications, compliance to regimen, patient education by the pharmacists, counseling and monitoring of patients, the therapeutic outcome of the received treatment and finally the frequency of emergency room visits by patients. Resul of the asthmatic patients (n = 122), were selected randomly, 32% met the criteria for wellcontrolled asthma, high proportions 61.5% for not well-controlled asthma, and 6.6% for very poorly controlled asthma. With statistically significant relation between asthma not well control and ages (13-73) years (p = 0.001), insignificant relation between not well-controlled asthma and females gender (p = 0.605), unemployed or unable to work showed insignificant relation with not well-controlled asthma, insignificant relation between illiterate patients and very poorly controlled asthma (p = 0.262), significant relation between asthma control and asthma severity Available online: www.ijipsr.com November Issue 2649

level (p = 0.000), significant relation between the prescribed drugs and asthma severity level (p = 0.000) and significant relation between asthma control and the prescribed drugs (p = 0.058). Fig.1: Relation between the prescribed drugs versus age Insignificant relation between the prescribed drugs and age (p=0.123) Fig. 2: Relation between the prescribed drugs versus gender Insignificant relation between the prescribed drugs and gender ( p=0.288) Available online: www.ijipsr.com November Issue 2650

Fig. 3: Relation between the prescribed drugs versus educational status Insignificant relation between the prescribed drugs and educational status (p=0,703) Fig.4: Relation between the prescribed drugs versus occupation Insignificant relation between the prescribed drugs and occupation (p=0,164) Available online: www.ijipsr.com November Issue 2651

Fig.5: Relation between the prescribed drugs versus asthma severity level Significant relation between the prescribed drugs and asthma severity level (p=0.000) Fig.6: Relation between asthma controls versus age Statistically significant relation between asthma control and age ( p= 0.001) Available online: www.ijipsr.com November Issue 2652

Fig.7: Relation between asthma controls versus gender Statistically insignificant relation between asthma control and gender ( p=0.605) Fig.8: Relation between asthma controls versus educational status Statistically insignificant relation between asthma control and educational status (p=0.262) Available online: www.ijipsr.com November Issue 2653

Fig.9: Relation between asthma controls versus occupation Statistically insignificant relation between asthma control and occupation (p=0.715) Fig.10: Relation between asthma controls versus the prescribed drugs Statistically significant relation between asthma control and the prescribed drugs (p=0.058) Available online: www.ijipsr.com November Issue 2654

Fig.11: Relation between asthma controls versus asthma severity level Statistically significant relation between asthma control and asthma severity level (p=0.000) CONCLUSIONS In this study, 122 patients selected randomly involved between 13 years to 73 years in Khartoum State hospitals. Rate of Asthma control was (61.5%) patients with asthma were poorly controlled. The level of asthma severity was moderate persistent Asthma. Most of the patients were prescribed combination of medications which were salbutamol inhaler plus Budesonide.formoterol160.Mcg. this research shows statistically significant relation between asthma not well control and ages > 73, insignificant relation between not well-controlled asthma and females gender, unemployed or unable to work showed insignificant relation with not wellcontrolled asthma, insignificant relation between illiterate patients and very poorly controlled asthma, significant relation between asthma control and asthma severity level, significant relation between the prescribed drugs and asthma severity level and significant relation between asthma control and the prescribed drugs. Finally, patient counseling with clinical pharmacist aided better patient understanding of their illness and the role of medications in its treatment, improving medication adherence, knowledge and attitude regarding the disease. ACKNOWLEDGMENT I would like to express my thanks and deep appreciation to Omdurman Islamic University, College of Postgraduates Studies, and Faculty of Pharmacy. I would like also to thanks Alnaw Teaching Hospital for the participation in this study. Available online: www.ijipsr.com November Issue 2655

REFERENCES 1. Clausen and Bosse, (2009) British national formulary. Germany : Martin, J., Ahmed, I.H., Allison, S.P., Atherton, J.C., Baglin,T. P., Baigent, C. N., Barnes, R. J., Bateman, D. N., Bloom, S. L., Bowsher, D. 2. El Sony, A. I., Chiang, C.Y., Malik, E., Hassanain, S. A., Hussien, H., and Khamis, A. H., (2013), Standard case management of asthma in Sudan: a pilot project, International Union Against Tuberculosis and Lung Disease, 3(3), PP: ( 247 252) 3. Harman, J. and Markham, S.,(2006) Asthma Management Handbook. Australia: Brown, C., Brun, S., Burdon, J., Fardy, H.J., Hancock, C.H., Hodge, L., Isles, A., Jersmann, H., Kemp, A., Kotsirilos, V., Latimer, K., Meyer, A., Mullins, R. 4. Kelly, H.W. and Sorkness C. A., (2005) pharmacotherapy. New York Chicago: Joseph, T., Talbert, R. L., Yee, G. C.,. Matzke, G.R., Wells, B.G., Posey, L. M. 5. Osman, A., Hassan, I.A., and Izham, M., (2012), Are Sudanese community pharmacists capable to prescribe or demonstrate asthma inhaler devices to patrons.a mystery patient study. Pharmacy practice, 10 (2), PP: (110-115). 6. World Health Organization, (2014), Chronic Respiratory Diseases Asthma, Chronic Diseases and Health Promotion Department, pp: 1211. Available online: www.ijipsr.com November Issue 2656